<DOC>
	<DOCNO>NCT01301625</DOCNO>
	<brief_summary>The primary objective MitraClip System ANZ Clinical Trial gather real-world clinical health-economic outcome data support long-term safety , efficacy economic value MitraClip System continuum therapy treat MR . Specifically , follow clinical economic data collect : New York Heart Association ( NYHA ) Functional Class , Six-Minute Walk Test ( 6MWT ) distance , quality life ( QOL ) information , echocardiographic measure leave ventricular size function , data associate index hospitalization , rehospitalizations , concomitant medication discharge facility support MitraClip System economic analysis .</brief_summary>
	<brief_title>MitraClip System Australia New Zealand</brief_title>
	<detailed_description>The MitraClip System ANZ Clinical Trial prospective , observational , single arm , multicenter trial evaluate MitraClip device treatment mitral regurgitation ( MR ) . Patients enrol 15 investigational site throughout Australia New Zealand . Up 150 patient enrol . Patients consider enrol local general anesthesia administer MitraClip procedure . Patients follow discharge , 30 day , 6 month , 12 month 24 month . Investigational sit recruit consecutive patient meet trial enrollment criterion . Until enrollment MitraClip System ANZ Clinical Trial close , patient undergo procedure placement MitraClip device investigational site enrol MitraClip System ANZ Clinical Trial .</detailed_description>
	<mesh_term>Mitral Valve Insufficiency</mesh_term>
	<criteria>Age 18 year old . MR ≥ 3+ . Transseptal catheterization femoral vein access feasible . Placement MitraClip device mitral leaflet feasible . Mitral valve orifice area ≥ 4.0 cm2 . Written inform consent obtain . The patient agree return followup visit . Need emergency surgery , cardiac surgery . Coronary artery disease ( CAD ) , atrial fibrillation ( AF ) , valve disease . Prior mitral valve repair surgery , mechanical prosthetic valve , ventricular assist device ( VAD ) . Active endocarditis rheumatic heart disease ; leaflet degenerate endocarditis rheumatic disease . Transesophageal echocardiography ( TEE ) contraindicate . Known hypersensitivity contraindication trial procedure medication manage medically . Currently participate investigational drug trial another device trial yet complete primary endpoint interferes MitraClip System ANZ Clinical Trial . Pregnant planning pregnancy within next 12 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>MitraClip</keyword>
	<keyword>mitral regurgitation ( MR )</keyword>
	<keyword>mitral valve insufficiency</keyword>
	<keyword>percutaneous mitral valve repair</keyword>
	<keyword>congestive heart failure</keyword>
</DOC>